TLSA: Partnership with Precision

By John Vandermosten, CFA



Tiziana Update Call with Analysts and Investors

Precision BioSciences

On September 8, 2021 following the market close, Tiziana Life Sciences (NASDAQ:TLSA) hosted a web conference centered on its recent exclusive license agreement with Precision BioSciences (NASDAQ:DTIL) for foralumab lymphodepletion support of allogeneic chimeric antigen receptor T cell (CAR T) therapy in cancer. Precision specializes in allogeneic CAR T therapy which provides advantages over autologous CAR T. More broadly, Precision is a genome editing company offering its ARCUS genome editing program. Its primary clinical programs are in blood cancers including Non-Hodgkin lymphoma (NHL) and B cell acute lymphoblastic leukemia (B-ALL).

One of the key benefits of Precisions CAR T offering is that it can be administered off the shelf. Precision’s CAR T cells are specially engineered to delete 99% Cluster of Differentiation 3 (CD3) expression, a receptor that is normally found on effector T cells. Foralumab is an anti-CD3 fully human monoclonal antibody (mAb) and is expected to bind to T cell CD3 receptors, thereby preventing them from clearing the allogeneic CAR T cells. The use of foralumab can replace other conditioning agents such as cyclophosphamide, which is associated with neurotoxicity. Thus, adding foralumab to the therapy is expected to spare Precision’s T cells while suppressing the patient’s T cells, improving the side effect profile and allowing Precision’s T cells to have better efficacy.

Tiziana CEO, Dr. Kunwar Shailubhai, began the call with a review of foralumab. Foralumab is the only fully human anti-CD3 mAb. Much clinical development has been done on anti-CD3 mAb, namely OKT-3, a fully mouse anti-CD3 antibody developed by Johnson & Johnson and approved by the FDA. However, because of the mouse basis of the antibody, it elicited a strong, negative immune reaction and formation of anti-drug antibodies and stimulated cytokine release syndrome. OKT-3 was taken off the market as a result. But clinical efficacy was good. Thus, it was worth investigating the development of a fully human anti-CD3 antibody, especially for renal transplant or graft-versus-host-disease (GVHD). Visilizumab and teplizumab are follow-on humanized anti-CD3 antibodies previously developed by PDL Biopharma. Efficacy was good, but long-term treatment was limited by formation of anti-drug antibodies. To prevent the immune response to the mouse elements, Tiziana’s foralumab is a fully human anti-CD3 mAb, and has not elicited anti-drug antibodies in clinical work thus far and has not triggered immune reactions observed in previous anti-CD3 candidates.

Precision’s CAR T cells do not express CD3 and are not discernible to foralumab, making them an appropriate candidate for lymphodepletion. Proper lymphodepletion can extend the durability of the CAR T cell therapy and lower the risk of cancer recurrence. Cyclophosphamide and fludarabine chemotherapies are often used for lymphodepletion conditioning; however their use has been limited by neurotoxicity. Foralumab could replace other lymphodepleting agents, or even function by itself as a solution. Together, the allogeneic non-CD3-expressing CAR T with foralumab could provide better efficacy in currently unmanaged cancers.

Clinical Trials and Analyst Questions

Dr. Shailubhai updated on Tiziana’s clinical progress. In the last year and a half, four trials were completed including Phase I trials for oral and nasal foralumab which laid the foundation for Phase II, as well as oral foralumab in Crohn’s and nasal foralumab in multiple sclerosis. Tiziana also completed a preliminary trial in Brazil for COVID-19 and is currently targeting a Phase II for hospitalized COVID-19 patients.

During the Q&A session, topics began with teplizumab’s (ProventionBio) recent BLA Complete Response Letter (CRL). Teplizumab is a humanized anti-CD3 antibody being developed for prevention of Type 1 diabetes that recently received a CRL from the FDA for its candidate teplizumab. Shailubhai cited deficiencies with CMC and there appear to have been issues that the FDA cited with pharmacokinetic comparability as well.1  Tiziana management remains optimistic for foralumab, which is fully human and has not seen anti-drug antibody response thus far in clinical evaluation nor has immunotoxicity been observed. Shailubhai noted that autoimmune disorders could be another area where a fully-humanized anti-CD3 antibody could become useful.

Topics also reviewed the mechanism of lymphodepletion. When allogeneic (foreign) therapeutic CAR T cells are injected into the body, the patient’s immune cells may attack the CAR T cells that are intended to treat the patient. Thus, cancer progression is an issue especially if CAR T therapy is terminated prematurely by the patient’s own immune system. Lymphodepletion drugs are used to attenuate the patient’s immune system, thereby enhancing clinical outcomes. However, neurotoxicity is an issue for lymphodepletion agents. Foralumab binds to CD3, depleting the cells expressing it (patient’s non-CAR T cells), allowing the CAR T cells that were engineered and administered to work. Precision’s CAR T cells lack CD3 and can be used for long periods of time avoiding whole-body immunosuppression and toxicity.

Analyst questions then shifted direction towards Tiziana’s clinical progress and expectations for upcoming milestones. Tiziana completed Phase I nasal foralumab in COVID-19 with positive results. Foralumab was given once daily for ten consecutive days. Post-study analysis provided evidence that T regs were upregulated which is a favorable finding in light of a study conducted by Johns Hopkins where researchers found that T regs are depleted in COVID-19. By restoring T reg balance, foralumab may be able to provide clinical benefit for these patients.

Next steps for foralumab in Crohn’s Disease is a Phase II multicenter trial in the US and Europe. Management anticipates the Crohn’s study starting by end of this year or early next year. The nasal foralumab for secondary progressive multiple sclerosis (SPMS) program is underway and under the individual access program, one patient has completed three months of treatment. Management believes the data generated so far is favorable and nasal administration during the three months of therapy has shown no signs of toxicity. When complete, the data will be reviewed and will guide the next steps in conjunction with FDA guidance. Tiziana is also now considering a similar program in Europe.

Building on preliminary work in Brazil, Tiziana plans to target a total of 80 patients in multiple sites for its next trial of nasal foralumab in hospitalized COVID-19 patients. Tiziana must wait for the Agência Nacional de Vigilância Sanitária (ANVISA) or in English the Brazilian Health Regulatory Agency to grant approval to initiate the trial. Following approval, the trial should be able to begin a few weeks later.

Dr. Shailubhai concluded the call highlighting the recent additions to clinical leadership, Dr. Neil Graham, Dr. Kevin Schutz, as Tiziana continues its venture deeper into the clinic.


During an update call with investors Tiziana announced a deal with Precision BioSciences to use foralumab in allogeneic CAR T as a conditioning agent. This approach provides multiple benefits including the replacement of other immunosuppressive drugs that are associated with toxicity. We see this as a positive for the company, expanding the range of indications that can be pursued with this versatile anti-CD3 fully human mAb. The company is making progress in the rest of its portfolio as well, with a Phase II trial in Crohn’s Disease to start soon, an active trial in SPMS and a COVID trial that is also expected to begin in the next weeks.

SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR. 

DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks provides and Zacks receives quarterly payments totaling a maximum fee of $40,000 annually for these services. Full Disclaimer HERE.


1. Provention Bio Receives Complete Response Letter (CRL) to Biologics License Application (BLA) for Teplizumab for the Delay of Clinical Type 1 Diabetes (T1D) in At-risk Individuals – Jul 6, 2021

Internet Explorer Channel Network
News Related


Seven-figure sum in mind as Barcelona prepare surprise Man Utd swoop

Barcelona have reportedly expanded their midfield wishlist to include another Manchester United backup after recently looking at Donny van de Beek as well. © Getty Images Nemanja Matic; Victor Lindelof ... Read more »

Man Utd must fix 'mentality and tactics', says Pogba

Paul Pogba delivered a withering assessment of the state of Manchester United’s form after a 4-2 defeat to Leicester left the Red Devils already five points adrift in the Premier ... Read more »

Everton vs West Ham - Premier League: Live score and updates

© Provided by Daily Mail MailOnline logo Everton and West Ham meet at Goodison Park in the first of two Premier League fixtures on Sunday afternoon. The Toffees have made ... Read more »

Recap: Bennett hat trick powers Panthers to 5-1 win over Islanders

Sam Bennett provided all the offense the Florida Panthers needed in a 5-1 victory over the New York Islanders at FLA Live Arena. © Photo by Joel Auerbach/Getty Images Bennett ... Read more »

Demi Moore's Daughter Scout Willis Seriously Strips Down In Her New Music Video

© J.M. HAEDRICH/SIPA. Instead of conquering the acting world like her parents, Demi Moore and Bruce Willis’s daughter, Scout Willis, has decided to take on the music world. On Oct. ... Read more »

Black Poetry Day | A Louisville poet's perspective on recognizing the work of people who paved the way

Sunday is Black Poetry Day. It is the birthday of Jupiter Hammon, who was the first African American to have poetry published in the United States. This day celebrated the ... Read more »

Everyday tips for making great drip coffee

When it comes time to brew a pot of drip coffee at home you probably don’t give it much thought. While performing the basic task of pouring hot water over ... Read more »

Baffled Customer Can't Open Door After Driver Leaves Full Coffee Outside

Food delivery drivers are part of the fabric of society, from ordering takeaways for a night in to bringing us a McDonald’s breakfast when we’re hungover. © Maksym Belchenko/Getty Images ... Read more »

Billionaire Marc Lore outlines how he will build the inclusive, Utopian desert city Telosa

Marc Lore grew up wanting to be a farmer – reveling at the idea of “something growing from nothing” – all while watching his father unafraid to take chances with ambitious business ... Read more »

I Learn to Shoot a Bow

© Provided by The Atlantic Lisa Edi / Connected Archives           It is no River Jordan that flows here between the railroad tracks and the back ... Read more »

EXCLUSIVE: Mother's diary: Expert lists foods that new mothers should eat and avoid

If you are pregnant or have just given birth, it’s likely that you are no longer the one in-charge to decide what you can eat and whatnot, minus the cravings. ... Read more »

Ask The Doctor: How Difficult is It for Cancer Patients to Manage Long-COVID Symptoms?

© Provided by News18 Ask The Doctor: How Difficult is It for Cancer Patients to Manage Long-COVID Symptoms? A year and a half after the Coronavirus pandemic wrecked our collective ... Read more »

Arizona Cardinals at Cleveland Browns: Live stream, time, date, betting odds, how to watch

In one of the most intriguing matchups of the weekend, the undefeated Arizona Cardinals travel to Cleveland to take on the 3-2 Browns.  It’s been 47 years since the Cardinals ... Read more »

Terry McLaurin, Antonio Gibson set to play for Washington

© Provided by NBC Sports Friday additions to the injury report are rarely a good thing, but it doesn’t look like Washington wide receiver Terry McLaurin‘s going to miss Sunday’s ... Read more »

Live stream Dallas Cowboys at New England Patriots: Time, betting odds, how to watch

The Dallas Cowboys haven’t beaten the New England Patriots in the Bill Belichick era. Of course, those games – 0-5  vs. the Patriots since 2003 – coincide with the Tom Brady era, ... Read more »

At least 15 dead and dozens missing in India floods

At least 15 people have been killed in floods in southern India after heavy rains caused rivers to overflow, cutting off towns and villages. © Getty Images A resident rescues ... Read more »

Stop handing out free money (and other ideas for getting the economy back on track)

Supply chain shortages and inflation are hurting consumers and Democratic election prospects in 2022 and 2024. The Biden administration, no doubt aware of this possibility, is taking action to address ... Read more »

Report: Chiefs are expected to start Juan Thornhill over Daniel Sorensen

© Provided by NBC Sports Chiefs defensive coordinator Steve Spagnuolo defended safety Daniel Sorensen against critics this week, but it seems neither he nor the rest of the team’s decision ... Read more »

When did the Penguins last start without their superstars?

Oct. 10, 2003. © Photo by Rick Stewart/Getty Images Chris Drury of the Buffalo Sabres fights for the puck against Milan Kraft as Brooks Orpik watches, on November 14, 2003, ... Read more »

Parkinson's disease: The ‘often overlooked' sign which can occur before motor symptoms

Tremors, muscle stiffness and slowness of movement are all common early symptoms of Parkinson’s – but there are also other signs to be aware of. Symptoms that may be noticeable ... Read more »

Flu vaccine warning: Efficiency 'could fail to make 40%' as Britons brace for 'twindemic'

With a lack of baseline level of immunity after a year when flu virus circulation has been very low, the potential of an ineffective vaccine could be set to create ... Read more »

Watch: Klopp and Liverpool bench react with awe after Mo Salah goal

Liverpool manager Jurgen Klopp was left with a stunned reaction on his face after witnessing Mohamed Salah’s latest wonder goal against Watford.  © PA Images Liverpool’s Mohamed Salah celebrates with ... Read more »

The Chicago startup incubator supporting indie craft beer brewers

Based in Chicago’s Logan Square neighborhood, Pilot Project is a brewery incubator, tasting room, and café that was founded as a collaborative and artistically curious space to help support talented brewers ... Read more »

Easy On Me lyrics explained: Meaning behind Adele's new song as she opens up about her divorce

Adele has released her first song in more than five years, and fans are not disappointed. The video for Easy on Me, posted on YouTube at midnight, has already accumulated ... Read more »

San Francisco is a city defined entirely by change. But not all change is created equal.

Every city is defined to an extent by reputation. When you hear about Los Angeles, you likely envision the smog-obscured vistas, movie stars, traffic jams and warm beaches that make ... Read more »

12 Most Googled Questions About Dogs Answered

Much of dog life remain a mystery to us humans. © smrm1977/Getty Images A dog’s nose is supposed to be wet While many turn to Google to try and understand ... Read more »

6 Luxury Pens That Will Give Your Desk an Instant Upgrade

If you’re in the market for an elegant, well-made writing pen to add to your own desk or to gift to a loved one, we have you covered. We’ve rounded ... Read more »

Get Microsoft Office for free: How to get Word, Excel, PowerPoint at no cost

Whether it’s for work or personal use, you’ll probably need to access a Microsoft Word document, a PowerPoint presentation or other basic tools found in Microsoft 365 at some point. The service, ... Read more »

These Latinx Tik Tok creators are making history

One of the greatest sources of anxiety for Alaina Castillo has been the letter R. © Provided to CNN Top row, right to left: Matisse Azul Rainbolt and Jesús Morales. ... Read more »

China's new hypersonic missile demonstrated an advanced space capability that caught US intelligence by surprise, report says

© Raytheon Missiles & Defense/Reuters Hypersonic Air-breathing Weapons Concept (HAWC) missile in seen in an artist’s conception. Raytheon Missiles & Defense/Reuters In August, China tested a hypersonic missile that orbited ... Read more »

13-year-old Alabama boy shot and killed after bullets fly through bedroom

A 13-year-old Alabama died on Friday after being shot in the head in an apparent drive-by shooting. © iStock A police officer in front of a police car Tuscaloosa police ... Read more »

Bill Clinton Expected to Be Discharged From Hospital on Sunday

SUNDAY, Oct. 17, 2021 (HealthDay News) — A spokesperson for former President Bill Clinton said late Saturday that the 75-year-old will be discharged from a California hospital on Sunday, CNN ... Read more »

This Top-Rated Toothbrush Flosses Your Teeth While You Brush — and It's on Sale for 24 Hours Only

Growing up, you’re taught to brush your teeth twice a day, but a not-so-harped-on addition to your bedtime routine is flossing — even though it’s just as important as brushing ... Read more »

Obama steps in to gin up flagging Biden support

Still acclimating to the post-White House political spotlight, former President Barack Obama is back ginning up enthusiasm for President Joe Biden and other Democrats as the incumbent struggles to unite ... Read more »

FCC head Rosenworcel on way out because she's not liberal enough for Biden

Federal Communications Commission acting Chairwoman Jessica Rosenworcel is not expected to be nominated by President Joe Biden to serve in the role on a permanent basis, people familiar with the ... Read more »

Know what diet to eat for your unique skin type right here

We’ve often heard of the phrase ‘beauty is skin deep’. Well, let’s just say it’s true. Your skin is a reflection of your beauty, and what’s on the inside definitely ... Read more »

Steelers inside linebackers coach Jerry Olsavsky takes leave after wife's death

Steelers inside linebackers coach Jerry Olsavsky is away from the team after the death of his wife. © Provided by NBC Sports Rayme Olavsky was 45 years old. She and ... Read more »

The CIA should leave diplomacy to diplomats

CIA Director Bill Burns is a lifelong career diplomat and a former deputy secretary of state. He’s also an ambitious man. © Provided by Washington Examiner Under ordinary circumstances, there ... Read more »

Windgate: 'Paper Routes: Arkansas Women to Watch 2021'

We use paper every day. It is a flexible and adaptable material capable of taking many forms and purposes. The diverse levels of value we assign to paper matches its ... Read more »